BioNTech SE

BioNTech SE

World Rank (Jan-05-2024)
686
Market Cap (Jan-05-2024)
26.909 Billion USD
World Rank (Jul-30-2023)
725
Market Cap (Jul-30-2023)
25.887 Billion USD
World Rank (Jan-07-2022)
369
Market Cap (Jan-07-2022)
51.375 Billion USD
World Rank (Jan-01-2021)
924
Market Cap (Jan-01-2021)
19.629 Billion USD
Company Rank in Country in 2023
Rank in Germany in July-2023 is 25
Headquarters Country
Germany
Nasdaq / NYSE Code
BNTX
Market Cap (Mar-08-2026)
24.36
Chairman
Ugur Sahin
Employee Count
4,530
Employee Count as of Date
As on 2022
World Region
Europe
World Subregion
Western Europe
Annual Revenue in USD
19,085 Million USD
Annual Operating Income in USD
13,939 Million USD
Annual Net Income in USD
10,402 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Total Assets in USD
25,666 Million USD
Total Liabilities in USD
3,554 Million USD
Total Equity in USD
22,112 Million USD
Balance Sheet for Period Ending
Dec-2022 ending year
Business Sector
Healthcare
Biotechnology
Biopharmaceutical
Pharmaceutical
Company Website
BIONTECH SE
Wikipedia
Wikipedia
Yahoo
Yahoo @ Nasdaq
Company Profile

BIONTECH SE is biotechnology company with headquarters is in Germany.

Annual Results Summary

BIONTECH SE - Annual Results - Revenue and Net Income - in Million EUR:

Year - EndingRevenueNet Income
Dec-20242,751-665 (Loss)
Dec-20233,819930
Dec-202217,3109,434
Dec-202118,97610,292
Dec-202048215
Dec-2019108-179 (Loss)
Dec-2018127-48
Balance Sheet Summary

Total Assets as on Dec-2024 was 22,529 Million EUR.

Total Liabilities as on Dec-2024 was 3,118 Million EUR.

Total Equity as on Dec-2024 was 19,411 Million EUR.

Founded Year
2008
IPO Year
2019
Stock Exchange
Nasdaq
Company SubCategory
Top Healthcare Companies in Europe
Top Pharmaceutical Companies in Europe
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Biological Products (No Diagnostic Substances)

Share